TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel–Thrombolysis in Myocardial Infarction) evaluated prasugrel compared with clopidogrel in patients with acute coronary syndromes.
MAIN RESULTS:
Prasugrel versus clopidogrel in patients with acute coronary syndromes
N Engl J Med. 2007 Nov 15;357(20):2001-15.
PRESENTATIONS
OTHER PUBLICATIONS
Cytochrome p-450 polymorphisms and response to clopidogrel. N Engl J Med. 2009 Jan 22;360(4):354-62.